US Bancorp
TEVA icon

US Bancorp’s Teva Pharmaceuticals TEVA Stock Holding History

US Bancorp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.28M Sell
155,892
-26,073
-14% -$868K 0.01% 602
2026
Q1 		$5.48M Buy
181,965
+129,497
+247% +$4.17M 0.01% 562
2025
Q4 		$1.64M Buy
52,468
+42,694
+437% +$1.05M ﹤0.01% 962
2025
Q3 		$197K Buy
9,774
+13
+0.1% +$228 ﹤0.01% 2012
2025
Q2 		$164K Sell
9,761
-1,051
-10% -$17K ﹤0.01% 2160
2025
Q1 		$166K Buy
10,812
+656
+6% +$11.7K ﹤0.01% 2113
2024
Q4 		$224K Buy
10,156
+524
+5% +$9.53K ﹤0.01% 1970
2024
Q3 		$174K Sell
9,632
-13,404
-58% -$235K ﹤0.01% 2102
2024
Q2 		$374K Buy
23,036
+14,846
+181% +$229K ﹤0.01% 1664
2024
Q1 		$116K Buy
8,190
+4,362
+114% +$55K ﹤0.01% 2289
2023
Q4 		$40K Buy
3,828
+1,023
+36% +$9.55K ﹤0.01% 2775
2023
Q3 		$28.6K Buy
2,805
+980
+54% +$9.13K ﹤0.01% 2714
2023
Q2 		$13.7K Sell
1,825
-8,295
-82% -$67.3K ﹤0.01% 3142
2023
Q1 		$89.6K Sell
10,120
-427
-4% -$4.22K ﹤0.01% 2246
2022
Q4 		$96.2K Sell
10,547
-158
-1% -$1.38K ﹤0.01% 2216
2022
Q3 		$87K Buy
10,705
+511
+5% +$4.52K ﹤0.01% 2261
2022
Q2 		$77K Sell
10,194
-1,139
-10% -$9.92K ﹤0.01% 2362
2022
Q1 		$106K Sell
11,333
-365
-3% -$3.05K ﹤0.01% 2263
2021
Q4 		$94K Buy
11,698
+182
+2% +$1.64K ﹤0.01% 2333
2021
Q3 		$112K Sell
11,516
-991
-8% -$9.28K ﹤0.01% 2238
2021
Q2 		$124K Sell
12,507
-1,960
-14% -$20.7K ﹤0.01% 2198
2021
Q1 		$167K Sell
14,467
-1,549
-10% -$17.8K ﹤0.01% 2004
2020
Q4 		$155K Sell
16,016
-200
-1% -$1.92K ﹤0.01% 1990
2020
Q3 		$146K Sell
16,216
-2,783
-15% -$29.4K ﹤0.01% 1905
2020
Q2 		$234K Sell
18,999
-515
-3% -$5.82K ﹤0.01% 1669
2020
Q1 		$175K Buy
19,514
+7,756
+66% +$79.5K ﹤0.01% 1731
2019
Q4 		$115K Sell
11,758
-2,687
-19% -$24K ﹤0.01% 2108
2019
Q3 		$99K Sell
14,445
-12,452
-46% -$95.4K ﹤0.01% 2164
2019
Q2 		$248K Sell
26,897
-18,061
-40% -$218K ﹤0.01% 1738
2019
Q1 		$705K Sell
44,958
-79,135
-64% -$1.4M ﹤0.01% 1229
2018
Q4 		$1.91M Sell
124,093
-41,807
-25% -$857K 0.01% 756
2018
Q3 		$3.57M Buy
165,900
+17,529
+12% +$407K 0.01% 609
2018
Q2 		$3.61M Buy
148,371
+100,518
+210% +$2.05M 0.01% 594
2018
Q1 		$818K Sell
47,853
-3,181
-6% -$62.1K ﹤0.01% 1191
2017
Q4 		$968K Sell
51,034
-30,338
-37% -$456K ﹤0.01% 1109
2017
Q3 		$1.43M Sell
81,372
-17,286
-18% -$389K ﹤0.01% 924
2017
Q2 		$3.28M Sell
98,658
-11,568
-10% -$358K 0.01% 599
2017
Q1 		$3.54M Sell
110,226
-17,420
-14% -$594K 0.01% 575
2016
Q4 		$4.63M Sell
127,646
-93,877
-42% -$3.75M 0.02% 483
2016
Q3 		$10.2M Sell
221,523
-63,777
-22% -$3.33M 0.04% 324
2016
Q2 		$14.3M Sell
285,300
-73,792
-21% -$3.93M 0.05% 267
2016
Q1 		$19.2M Sell
359,092
-27,966
-7% -$1.64M 0.08% 212
2015
Q4 		$25.4M Sell
387,058
-25,332
-6% -$1.57M 0.1% 174
2015
Q3 		$23.3M Sell
412,390
-43,120
-9% -$2.8M 0.1% 184
2015
Q2 		$26.9M Buy
455,510
+17,650
+4% +$1.09M 0.1% 176
2015
Q1 		$27.3M Buy
437,860
+2,218
+0.5% +$129K 0.1% 169
2014
Q4 		$25.1M Buy
435,642
+19,363
+5% +$1.08M 0.1% 182
2014
Q3 		$22.4M Buy
416,279
+43,110
+12% +$2.28M 0.09% 186
2014
Q2 		$19.6M Buy
373,169
+84,925
+29% +$4.34M 0.08% 203
2014
Q1 		$15.2M Buy
288,244
+30,884
+12% +$1.43M 0.06% 236
2013
Q4 		$10.3M Sell
257,360
-30,965
-11% -$1.22M 0.04% 305
2013
Q3 		$10.9M Sell
288,325
-12,685
-4% -$495K 0.05% 274
2013
Q2 		$11.8M Buy
+301,010
New +$11.7M 0.05% 252

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

US Bancorp's TEVA Position: Q2 2026 in Review

US Bancorp reduced its Teva Pharmaceuticals (TEVA) stake by 14% in Q2 2026, selling an estimated $868K and leaving 155,892 shares worth $5.28M. The position accounts for 0.01% of the portfolio, ranked #602.

US Bancorp first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $27.3M in Q1 2015. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • US Bancorp held 155,892 shares of Teva Pharmaceuticals worth $5.28M as of Q2 2026.
  • US Bancorp sold 26,073 Teva Pharmaceuticals shares in Q2 2026, an estimated $868K.
  • Teva Pharmaceuticals made up 0.01% of US Bancorp's portfolio in Q2 2026, its #602 holding.
  • US Bancorp first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • US Bancorp's Teva Pharmaceuticals position peaked at $27.3M in Q1 2015.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.